APR 20, 2021 7:30 AM PDT

Scientists Map the Genetic Landscape of COVID Infections

WRITTEN BY: Tara Fernandez

Scientists have identified 65 human immune genes activated during SARS-CoV-2 infection. This finding provides valuable insights into why some individuals experience more severe COVID symptoms than others and paves the way for novel therapeutic interventions.

The study, published in Molecular Cell, was led by Sumit K. Chanda and colleagues from Sanford Burnham Prebys. They found that interferon-stimulated genes, or ISGs, play a key role in determining COVID severity. Interferons are signaling proteins that are central to the body’s ability to protect itself from viral attacks.

"We wanted to gain a better understanding of the cellular response to SARS-CoV-2, including what drives a strong or weak response to infection," said Chanda.

"We've gained new insights into how the virus exploits the human cells it invades, but we are still searching for its Achilles heel so that we can develop optimal antivirals."

The researchers found that a panel of 65 ISGs controlled the dynamics of SARS-CoV-2 infection in a multifaceted way, inhibiting the coronavirus’ ability to invade cells and stopping the virus from replicating in human cells.

"We identified eight ISGs that inhibited both SARS-CoV-1 and CoV-2 replication in the subcellular compartment responsible for protein packaging, suggesting this vulnerable site could be exploited to clear the viral infection," said the study’s first author, Laura Martin-Sancho.

"This is important information, but we still need to learn more about the biology of the virus and investigate if genetic variability within these ISGs correlates with COVID-19 severity."

The team plans to expand the study by investigating the infection dynamics of SARS-CoV-2 variants, focusing on how these may undercut vaccination efforts. "It's vitally important that we don't take our foot off the pedal of basic research efforts now that vaccines are helping control the pandemic," commented Chanda. 

 




Sources: EurekAlert, Molecular Cell.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 19, 2021
Cancer
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
AUG 19, 2021
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
Early-onset colorectal cancer progresses in the same way as average onset colorectal cancer. The corresponding study was ...
AUG 18, 2021
Neuroscience
Histamine Regulates Serotonin Levels in Depression
AUG 18, 2021
Histamine Regulates Serotonin Levels in Depression
Heightened histamine levels from inflammation inhibit the effects of the mood-regulating neurotransmitter serotonin in t ...
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
Loading Comments...